Neuropathology, biochemistry, and biophysics of α-synuclein aggregation

被引:438
作者
Uversky, Vladimir N. [1 ]
机构
[1] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[2] Russian Acad Sci, Inst Biol Instrumentat, Moscow, Russia
关键词
aggregation; fibril; natively unfolded protein; neurodegeneration; synucleinopathies; alpha-synuclein;
D O I
10.1111/j.1471-4159.2007.04764.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aggregation of alpha-synuclein, an abundant and conserved presynaptic brain protein, is implicated as a critical factor in several neurodegenerative diseases. These diseases, known as synucleinopathies, include Parkinson's disease, dementia with Lewy bodies (LBs), diffuse LB disease, the LB variant of Alzheimer's disease, multiple system atrophy, and neurodegeneration with brain iron accumulation type I. Although the precise nature of in vivo alpha-synuclein function remains elusive, considerable knowledge has been accumulated about its structural properties and conformational behavior. alpha-Synuclein is a typical natively unfolded protein. It is characterized by the lack of rigid, well-defined, 3-D structure and possesses remarkable conformational plasticity. The structure of this protein depends dramatically on its environment and it accommodates a number of unrelated conformations. This paper provides an overview of the biochemistry, biophysics, and neuropathology of a-synuclein aggregation.
引用
收藏
页码:17 / 37
页数:21
相关论文
共 307 条
[1]   Expanding insights of mitochondrial dysfunction in Parkinson's disease [J].
Abou-Sleiman, PM ;
Muqit, MMK ;
Wood, NW .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (03) :207-219
[2]   Tubulin seeds α-synuclein fibril formation [J].
Alim, MA ;
Hossain, MS ;
Arima, K ;
Takeda, K ;
Izumiyama, Y ;
Nakamura, M ;
Kaji, H ;
Shinoda, T ;
Hisanaga, S ;
Uéda, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (03) :2112-2117
[3]   Aluminum-containing antacids as a cause of idiopathic Parkinson's disease [J].
Altschuler, E .
MEDICAL HYPOTHESES, 1999, 53 (01) :22-23
[4]   Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein [J].
Arawaka, S ;
Saito, Y ;
Murayama, S ;
Mori, H .
NEUROLOGY, 1998, 51 (03) :887-889
[5]   NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy [J].
Arima, K ;
Uéda, K ;
Sunohara, N ;
Arakawa, K ;
Hirai, S ;
Nakamura, M ;
Tonozuka-Uehara, H ;
Kawai, M .
ACTA NEUROPATHOLOGICA, 1998, 96 (05) :439-444
[6]   Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies [J].
Arima, K ;
Uéda, K ;
Sunohara, N ;
Hirai, S ;
Izumiyama, Y ;
Tonozuka-Uehara, H ;
Kawai, M .
BRAIN RESEARCH, 1998, 808 (01) :93-100
[7]   Pharmacological prevention of Parkinson disease in Drosophila [J].
Auluck, PK ;
Bonini, NM .
NATURE MEDICINE, 2002, 8 (11) :1185-1186
[8]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[9]  
Baba M, 1998, AM J PATHOL, V152, P879
[10]   α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores [J].
Bayer, TA ;
Jäkälä, P ;
Hartmann, T ;
Havas, L ;
McLean, C ;
Culvenor, JG ;
Li, QX ;
Masters, CL ;
Falkai, P ;
Beyreuther, K .
NEUROSCIENCE LETTERS, 1999, 266 (03) :213-216